SIGA Technologies, Inc. (SIGA) Financial Analysis & Valuation | Quarter Chart

SIGA Technologies, Inc. (SIGA)

SIGA
Price: $6.54
Fair Value: 🔒
🔒score
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies... more
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security a... more
Description Shares
Market Cap$468.30MExchangeNASDAQ
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryUSCEODiem Nguyen
IPO Date1997-09-10CAGR0.29%
Employees46Websitewww.siga.com
Div. Yield9.17%Payout Ratio0.52%
Buy Back Yield0.01%Total Yield9.18%
SIGA chart loading...
Fundamentals Technicals
Enterprise Value$284.06MP/E Ratio5.74
Forward P/E3.2PEG Ratio—
P/S Ratio2.61P/B Ratio2.23
P/CF Ratio3.93P/FCF Ratio3.94
EPS$1.14EPS Growth 1Y-14.47%
EPS Growth 3Y-29.21%EPS Growth 5Y154.57%
Revenue Growth 1Y-0.85%Gross Margin0.73%
Operating Margin0.56%Profit Margin0.46%
ROE0.41%ROA0.35%
ROCE0.48%Current Ratio10.09
Quick Ratio8.52Cash Ratio8.03
Debt/Equity0Interest Coverage—
Altman Z Score16.74Piotroski Score7

View SIGA Technologies, Inc. financial charts →